Shareholding disclosure
Astellas Pharma Inc
Declared position
3%
Threshold
Fell below threshold
Timeline
Published
09.11.2016
Transaction
03.11.2016
Voting rights breakdown
Voting rights acquired0%
Voting rights sold0%
Below threshold3%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TAGB600019
Beneficial owner
Astellas Pharma Inc
Declared address
Astellas Pharma Inc., Tokyo 103-8411
Astellas Venture Capital LLC which is a 99.9% subsidiary of Astellas US Holding, Inc.,1 Astellas Way Northbrook, IL 60062, which is wholly owned subsidiary of Astellas Pharma Inc., Japan. (beneficial owner)
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open